Infleqtion, UChicago, and MIT Unite to Develop Breakthrough Cancer Solutions with AI and Quantum Algorithms.

Předmět:
Zdroj: Drug Week; 9/29/2023, p293-293, 1p
Abstrakt: Keywords: Algorithms; Biomarkers; Cancer; Cancer Biomarkers; Carcinoma Biomarkers; Diagnostics and Screening; Drugs and Therapies; Genetics; Health and Medicine; Infleqtion; Oncology; Personalized Medicine; Personalized Therapy; Software; Technology EN Algorithms Biomarkers Cancer Cancer Biomarkers Carcinoma Biomarkers Diagnostics and Screening Drugs and Therapies Genetics Health and Medicine Infleqtion Oncology Personalized Medicine Personalized Therapy Software Technology 293 293 1 09/25/23 20230929 NES 230929 2023 SEP 26 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Infleqtion, the world's quantum information company, announced that it had been awarded funding from Wellcome Leap's Quantum for Bio (Q4Bio) program with a team of renowned researchers and medical doctors at the University of Chicago (UChicago) and Massachusetts Institute of Technology (MIT). "Through our collaborations with the University of Chicago and MIT, we will unlock the potential of AI and quantum algorithms to derive knowledge across multiple forms of medical data, reshaping cancer diagnostics and treatment strategies. [Extracted from the article]
Databáze: Complementary Index